You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ROIV Sale Disclosure
Venker Eric · SEC Form 4 · Filed Jun 26, 2026
Sale
Calculated transaction value
$5.08M
Venker Eric President & Immunovant CEO
ROIV
Roivant Sciences Ltd
ROIV
Transaction date
Jun 24, 2026
Public filing date
Jun 26, 2026
Filing lag
Filed 2 days later
ROIV daily price context
Close on/before transaction
$34.01
Jun 24, 2026
First close after public filing
$34.73
Jun 29, 2026
30-day return after filing
-0.03%
Through Jul 27, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 153,766 shares @ $33.05
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001635088-26-000071
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$7.4M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Roivant Sciences Ltd. ROIV Current | Sale | Jun 24, 2026 | $5.08M |
| Roivant Sciences Ltd. ROIV | Sale | Jun 24, 2026 | $1.55M |
| Roivant Sciences Ltd. ROIV | Exercise | Jun 24, 2026 | $0 |
| Roivant Sciences Ltd. ROIV | Exercise | Jun 24, 2026 | $770K |